26Indexed trials
mesh condition
COVID-19
Intelligence
COVID-19 intelligence: 26 indexed trials, 1 recruiting studies, 25 sponsors across 11 countries.
1Recruiting
25Sponsors
11Countries
Leading sponsors
Assistance Publique - Hôpitaux de Paris20 recruiting
CanSino Biologics Inc.10 recruiting
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla10 recruiting
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal10 recruiting
Duke University10 recruiting
Fondation Lenval10 recruiting
Centre hospitalier de Ville-Evrard, France10 recruiting
Hôpital NOVO10 recruiting
Istanbul University10 recruiting
Jordi Alonso10 recruiting
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's10 recruiting
Aarhus University Hospital10 recruiting
Geographic activity
France9trials
United States5trials
Chile2trials
Spain2trials
Canada2trials
Russia1trials
Taiwan1trials
Turkey (Türkiye)1trials
Belgium1trials
Denmark1trials
Brazil1trials
Leading interventions
Beck Depression Inventory (BDI) scale1trials
Brief Psychiatric Rating Scale1trials
COVID-19 RT-PCR test1trials
COVID-19 Vaccine Education Campaign1trials
COVID-19 infection1trials
COVID-19 swap test PCR1trials
Cannabidiol1trials
Connor-Davidson Resilience Scale 10 items (CD-RISC 10)1trials
Depression, Anxiety and Stress Scale1trials
EMDR1trials
Ethyl methyl hydroxypyridine succinate + Meldonium1trials
Active Smell Training (ST)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.